Transfusion medicine is constantly evolving, and Pathogen Reduction Technologies (PRTs) are at the forefront, offering distinct advantages and challenges. PRTs aim to minimize the risk of infections transmitted through transfusion while addressing immune responses associated with blood product transfusion. However, the efficacy of PRT-treated blood products can be compromised, potentially escalating the demand for blood…